Dow Down0.21% Nasdaq Down0.84%

Biogen Idec Inc. (BIIB)

-NasdaqGS

213.02 Down 1.11(0.52%) Aug 30, 4:00PM EDT|After Hours : 213.01 Down 0.01 (0.00%) Aug 30, 4:42PM EDT

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2012Dec 31, 2011Dec 31, 2010
Total Revenue 5,516,461   5,048,634   4,716,423  
Cost of Revenue545,494  466,780  400,262  
Gross Profit 4,970,967   4,581,854   4,316,161  
Operating Expenses
Research Development1,334,919  1,219,602  1,248,604  
Selling General and Administrative1,622,562  1,409,969  1,289,611  
Non Recurring2,225  19,026  320,129  
Others202,204  208,566  208,928  
Total Operating Expenses3,161,910  2,857,163  3,067,272  
Operating Income or Loss 1,855,849   1,724,691   1,248,889  
Income from Continuing Operations
Total Other Income/Expenses Net46,048  (13,477)(18,983)
Earnings Before Interest And Taxes1,901,897  1,711,214  1,229,906  
Interest Expense -   -   -  
Income Before Tax1,901,897  1,711,214  1,229,906  
Income Tax Expense470,554  444,528  331,333  
Minority Interest -  (32,258)106,700  
Net Income From Continuing Ops1,426,825  1,234,428  1,005,273  
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income 1,380,033   1,234,428   1,005,273  
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares 1,380,033   1,234,428   1,005,273  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.